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Abstract.  Mutant V.24.1, a member of the End4 com- 
plementation group of temperature-sensitive CHO cells, 
is defective in secretion at the restrictive temperature 
(Wang,  R.-H., P. A.  Colbaugh, C.-Y. Kao, E.  A. 
Rutledge, and R. K.  Draper.  1990.  J.  Biol.  Chem. 
265:20179-20187;  Presley, J.  E, R. K.  Draper,  and 
D. T. Brown.  1991. J.  Virol.  65:1332-1339).  We have 
further investigated the secretory lesion and report three 
main findings.  First,  the block in secretion is not due 
to aberrant folding or oligomerization of secretory pro- 
teins in the endoplasmic reticulum because the hemag- 
glutinin of influenza virus folded and oligomerized at 
the same rate in mutant and parental cells at the restric- 
tive temperature.  Second,  secretory proteins accumu- 
lated in a compartment intermediate between the ER 
and the Golgi.  Several lines of evidence support this 
conclusion,  the most direct being the colocalization 
by immunofluorescence microscopy of influenza virus 
hemagglutinin  with a 58-kD protein that is known to 
reside in an intermediate compartment.  Third,  at the 
resolution of fluorescence microscopy, the Golgi com- 
plex in the mutant cells vanished at the restrictive 
temperature. 
ECR~a'ORV material  in  mammalian  cells  first  enters 
transport vesicles in the ER. Recent evidence suggests 
that material  is delivered next to a compartment inter- 
mediate between the ER and the Golgi where proteins may 
then be either recycled back to the ER or pass on to the cis- 
Golgi (3,  37, 43, 44, 49,  50).  Material  then  traverses  the 
Golgi complex and finally  enters the trans-Golgi  network 
where contents are sorted and eventually delivered either to 
the plasma membrane or to lysosomes (for reviews see 2, 17, 
38). The general mechanism of membrane movement from 
one organelle  to another during  secretion is believed to be 
vesicular transport,  which involves four main steps:  (a) the 
sorting of proteins to be transported from those to be left be- 
hind;  (b)  vesicle  formation;  (c)  vesicle  targeting  to  the 
specific acceptor membrane; and (d) vesicle fusion with the 
acceptor membrane. The molecular mechanisms  of some of 
these steps are just now beginning  to emerge. 
Major contributions to understanding  secretory transport 
at the molecular level have been made by combining  the 
genetic analysis of the secretory pathway in yeast (21, 32, 46) 
with the in vitro biochemical study of secretory transport in 
both mammalian  cells (for example,  see 2, 6, 58) and yeast 
(for example,  see  1,  42,  51). Progress  in  understanding 
secretion would also be advanced by isolating and analyzing 
secretion-defective  mutants in animal  cells.  We previously 
isolated  and  studied a  temperature-sensitive,  conditional- 
lethal mutant of CHO cells, termed V.24.1, that defined the 
End4 complementation group (7) and which had aberrant 
lysosomes at  the  restrictive  temperature  (8).  Subsequent 
studies  demonstrated  that  V.24.1 cells  were  defective  in 
secretion (39, 56).  In the present work, we used immuno- 
fluorescence microscopy and biochemical assays to demon- 
strate that the secretory block in the V.24.1 ceils prevents the 
export of material  from a compartment that is intermediate 
between the ER and the Golgi.  Interestingly,  the block in 
secretion  is correlated with the disappearance of the Golgi 
complex. A preliminary  report of this  work has appeared 
(Kao, C.-Y.,  P. A.  Colbaugh, and R. K.  Draper.  1990. J. 
Cell Biol.  111:199a). 
Materials and Methods 
Reagents 
TPCK-trypsin,  soybean  trypsin  inhibitor, protein A-sepharose CL-4B, 
polyacrylamide,  Tris base, MES, PMSF, aprotinin, sucrose, Triton X-100, 
nocodazole,  NP-40,  and bicinchoninic acid  (BCA) protein assay  reagent 
were purchased from Sigma Chemical Co. (St. Louis,  MO). Endoglycosi- 
dase D (endo D) and endoglycosidase  H (endo H) were from Boehringer 
Mannheim Biochernicals  (Indianapolis,  IN). Monensin was from Calbio- 
chem (La Jolla, CA). AcrylAide was from FMC Corporation (Rockland, 
ME).  Brefeldin  A  (BFA)  was  purchased  from  Epicentre  Technologies 
(Madison, WI), dissolved at 1 mg/ml in ethanol, and stored at -70~  be- 
fore use. Gamma.Bind G Agarose was from Genex Corporation (Galthers- 
berg, MD). Entensify  was from Du Pont-New  England Nuclear (Boston, 
MA). Tran35S-label was from ICN Radiochemicals  (Irvine, CA). 
1. Abbreviations usedin thispaper: BFA, brefeldin A; endo D, endoglycosi- 
dase D; endo H, endoglycosidase  H; GIcNAc, N-acetylglucosamine;  HA, 
hemagglutinin;  Man, rnannose. 
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Goat anti-HA (strain X31) antiserum was from Dr. R. Webster (Saint Jude 
Children's Hospital, Memphis, TN). Rabbit antimannosidase H (30) was 
provided by Drs. N. T. Ktistakis,  G. Bloom, and M. Roth (University of 
Texas Southwestern Medical Center, Dallas, TX). Rat mAb ABL-70 (anti- 
Golgp125;  Storrie,  B.,  Y.  Cha,  and J.  T.  August.  1988. J.  Cell Biol. 
lff7:760a; Cha, Y., L. M. Axterburn, M. C. W~fllingbam,  andJ. 1". August. 
1990. FASEB (Fed. Am. Soc.  Exp.  Biol.) Z  4:A1979.)  to a  125-kD Golgi 
protein, termed  hem anti-gp125, was donated by Dr. T. August (Johns Hop- 
kins University, School of Medichte,  Baltimore,  MD). Rabbit anti.p58 se- 
rum (44, 45) was from Dr. J.  Saraste  (Ludwig Institute for Cancer Re- 
search, Stockholm, Sweden).  Rabbit anti-BiP was  the gift of Dr.  M.-J. 
Gething (University of Texas Southwestern  Medical Center,  Dallas,  TX). 
Mouse mAb 3DI (antiribophorin II) was provided by Dr. D. Meyer (UCLA 
Medical School, Los Angeles,  CA).  Mouse antityrosinated tubulin was 
from Sigma Chemical Co. Fluorescent labeled secondary antibodies were 
from Jackson Immuno Research  Laboratories, Inc. (West Grove,  PA). 
Cells and Virus 
The isolation and culture of mutant cell line V.24.1 was described by Col- 
bangh etal. (7). The proPasation and use of recombinant influenza virus 
X31 was as described previously by Wang etal. (56). 
Folding of  Influenza Virus HA 
The extent of bemagglutinin (HA) folding within the ER was measured by 
its resistance to trypsin upon extraction from cells (9,  10). Cells were 
seeded in 35-ram culture dishes for 1-2 d before the experiment.  For virus 
infections at the restrictive temperature, cells were incubated at 41~  for 
4 h, shifted to 39.5~  and medium containing virus was added. After 1 h, 
the medium was changed to remove free virus and the incuba~on was con- 
tinned at 39.5~  for 4 h. Viral proteins were radiolabeled with Tran3SS- 
label for 5 win as described by Wang et el. (56). At different times after 
the pulse, the cells were 1F-~d with 350 ~tl of iysis buffer (1% NP-40, 50 
mM Tris, 150 mM NaCI, 10 mM EDTA, pH 8,0). The lysates were clarified 
by centrifugation in a Brinkman Microfuge for 10 rain and the protein con- 
centration was determined by BCA assay (Sigma Chemical Co.). 75/~g of 
protein from each lysate were treated with 100/tg/ml of TPCK trypsin for 
30 rain at 0~  Soybean trypsin inhibitor (final concentration I mg/ml) and 
aprotinin (0.1 TIU/mi) were added to stop the trypsin digestion.  HA was 
immunoprecipitated with goat anti-HA antibody and GammaBindG Aga- 
rose. The immunoprecipitated proteins were then analyzed on 12% SDS- 
polyacrylamide  gels (22) with AcrylAide as cross-linker.  The gels were 
treated with Entensify, dried and exposed to preflashed (23) Kodak  X-Omat 
AR film. 
Trimerization of  HA 
The trimerization of HA within the ER was determined by the rate of HA 
sedimentation  in sucrose gradients, as described by Copeland etal. (9) with 
minor modifications. Virus infection at the restrictive  temperature  and radio- 
labeling were as in the previous section. At times after radiolabeling,  cells 
were lysed with 500/tl of 1% Triton X-100, 20 mM MES, 30 mM Tris, and 
100 mM NaCI, pH 7.4, with protease inhibitors (1 mM PMSF, 0.1 TIU/mi 
aprotinin, and  100/tg/ml soybean  trypsin inhibitor). The lysates  were 
clarified by centrifugetion  in a microfuge  and layered on 5-25% (wt/vol) 
sucrose gradients in the lysis buffer without 1% Triton X-100. The gradients 
were centrifuged  in a rotor (model SW41, Beckman Instruments, Inc., Palo 
Alto, CA) at 40,000 rpm for 16.5 h at 20~  After centrifugetion,  0.5-mi 
fractions were collected from the top of the tubes. HA was immunoprecipi- 
tared from alternate fractions and electrophoresed in 7.5 % SDS-polyacryl- 
amide gels. 
Endo H Digestion 
Cells were grown on 35-ram plates for 1-2 d before the experiment. After 
virus infection and radiolabeling,  as described in the legend to Fig.  1, the 
cells were lysed for 20-30 rain on ice in 500 ~tl of lysis buffer containing 
protease inhihitors as described in the preceding paragraph. The lysatas 
were clarified by centrifugation in a Brinkman Micmfuge for 10 rain at 4~ 
and  HA  was  immunoprecipitated with anti-HA  antibodies and protein 
A-Sepharose. 30 t~l of 0.1% SDS in 50 mM sodium citrate,  pH 5.5, was 
added to each sample and boiled for 5 min. Two 12-t~l  aliquots were taken 
from each sample. One aliquot was mixed with 12 #1 of 50 mM citrate, pH 
5.5 containing 0.2 mU endo H, and the other was mixed with citrate buffer 
only. Digestion  was for 16 h at 37~  Laemmii sample buffer was added 
to  stop  the  digestion  and  HA  was  electrophoresed  in  7.5%  SDS- 
polyacrylamide  gels. Different forms of HA on the gel fluorographs  were 
quantitated using a laser scanning densitometer (model 30OK; Molecular 
Dynamics, Sunnyvale, CA). 
Endo D Digestion 
Virus-infected cells were prepared and lysed as for endo H digestion except 
350 #1 of lysis buffer was used.  Two 100-#1 aliquots  of each lysate were 
added to 100 #1 of 2.Sx digestion buffer (0.5 M sodium citrate,  6.25 mM 
EDTA, pH 6.35).  50/~1 of 10 mM Tris-HCl, pH 7.2, comaining 200 mM 
NaCI,  either with or without 1 mU Endo D were then added.  The tubes 
were tightly sealed and incubated at 37~  for 20 h. HA was immunoprecipi- 
tated and electrophoresed  as for endo H digestion. 
lmmunofluorescence Microscopy 
Cells were grown on 12-ram round No.  1 glass coverslips for 2-3 d before 
an experiment. Except when staining for the p58 antigen, cells were rinsed 
twice with PBS containing 1 mM MgCIz and 0.1 mM CaCIz and incubated 
in methanol at -20~  for 5-10 min to simultaneously fix and permeahilize 
the cells. After the methanol treatmem, cells were rinsed with PBS and in- 
cubated with 1% BSA (in PBS) for 15 min to block nonspecific protein bind- 
ing sites. Primary antibodies diluted in 1% BSA were added for 30 min at 
room temperature.  The cells were then rinsed with 1% BSA three times dur- 
ing a 20-rain period to wash away unbound primary antibodies. The same 
incubation and washing procedures were used for fluorescent-labelad  sec- 
ondary antibodies.  The cells were rinsed finally in double-distilled  water 
and mounted in 4 ~1 of Mowiol  (Polyscience  Inc., Warrington,  PA). 
Cells stained for p58 were  rinsed twice with PBS containing 1 mM 
MgCl2 and 0.1 mM CaClz,  fixed with 3% paraformaldehyde  (in PBS) for 
15-20 rain at room temperature,  the aldehyde was quenched with 50 mM 
NI-hCI for t0 rain, and cells were permeabilized with 0.05% Triton X-100 
in NET/gel (150 mM NaC1, 5 mM EDTA, 50 mM Tris, pH 7.4, 0~)5% NP- 
40, 0.25% gelatin,  0.02%  sodium azide)  for 15 rain. The cells were then 
rinsed three times with NET/gel solution and incubated for 45 rain at room 
temperature with anti-p58 antiserum diluted 1:100 in NET/gel.  After incu- 
bation with the antibody, the cells were washed with NET/gel five times dur- 
ing a 30-rain period with agitation, rinsed three times with PBS, and treated 
with methanol at -20~  for 5 rain. Staining for a second antigen, and add- 
ing secondary antibodies,  was as described at the beginning of this section. 
Samples were viewed with a Zeiss photoscope equipped with epi-fluores. 
cence illumination and a 63 ￿  Apochromat lens. Photography was with Ko- 
dak TMAX p3200 film (developed as EI 1,600) or Kodak TMAX 400 film. 
The bars shown on the prints represent 5 t~m. 
Results 
7Ime at the Restrictive Temperature  Required to 
Block ER to Golgi Transport in V.24.I Cells 
In V.24.1 cells, glycoproteins containing N-linked oligosac- 
charides do not acquire resistance to endo H at the restrictive 
temperature,  evidence that transport  from the  ER to the 
Golgi is blocked (39, 56). To see if this block was an early 
response to elevating the temperature, we measured the time 
at 41~  required to inhibit the acquisition of endo H resis- 
tance by HA. A summary of the procedure is diagrammed 
in Fig. I a: Cells were infected with influenza virus at 34~ 
shifted to 41~  for different times (AT), and labeled with 
Trans35S-label  for 5  rain  followed by a  30-min chase pe- 
riod. The sensitivity of HA to endo H was then determined 
(Fig. 1 b). With wild-type cells, HA was almost completely 
resistant to endo H when cells were labeled immediately af- 
ter raising the temperature to 41~  (AT = 0). This indicated 
that the 35 min used for the pulse and chase was sufficient 
time for HA to be transported from the ER to the Golgi or 
beyond. HA from the wild-type cells remained endo H resis- 
tant at AT  =  4 h. With V.24.1  cells, only 62% of the HA 
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quired  to block ER to Golgi 
transport  in  V.24.1 cells.  A 
summary of the procedure  is 
shown  in  A.  Cells  at  34~ 
were  infected  with  influenza 
virus and the temperature was 
increased  to  41~  Tranass  - 
label was added for 5 rain at 
different times after the tem- 
perature  change,  the  radio- 
label  was  removed,  and  the 
cells were incubated a further 
30  rain  in  medium  contain- 
ing  excess  cold  methionine 
and cysteine before they were 
lysed and HA was extracted. 
Endo H sensitivity was deter- 
mined as described  in Mate- 
rials  and  Methods.  The per- 
centage of total HA that was 
endo  H  sensitive  was  mea- 
sured  by densitometric  scan- 
ning and was: (lane 2)  12%; 
(lane 4) 22%; (lane 6) 38%; 
(lane 8) 52%; (lane 10) 94%; 
(lane 12) 96 %; (lane 14 ) 97 %. 
was endo H resistant by 35 min at 4 I~  (AT =  0), decreasing 
to 48% by 65 min (AT =  0.5 h) and falling to 6% by 95 rain 
(AT =  1 h). This relatively rapid inhibition of the acquisition 
of endo H resistance in V.24.1 cells indicates that the block 
of ER to Golgi transport is an early response to high temper- 
ature,  consistent  with  the  possibility  that  this  is  closely 
related to the primary lesion in the cells. 
Influenza Virus HA Remains Resistant 
to Digestion by Endo D in E24.1 Cells at 
the Restrictive Temperature 
N-linked oligosaccharides of glycoproteins in the Mannose9 
N-acetylglucosamine2 (Man9GlcNAc2)  form within the  ER 
are resistant to digestion by endo D.  However, once in the 
Golgi the oligosaccharide chains are trimmed by a-l,2-man- 
nosidase I to the Man5 GIcNAc2 species (4), which is sensi- 
tive to digestion by endo D (29, 52). In addition, after oligo- 
saccharide side chains acquire more GIcNAc by the action 
of N-acetylglucosamine transferase I, they are again resis- 
tant to endo D, and upon removal of more mannose by Golgi 
mannosidase II, they become resistant to endo H. Since HA 
did not become resistant to endo H, it was presumably not 
modified by N-acetylglucosamine transferase I and mannosi- 
dase II, but could have been present in the Man~GlcNAc2 
form  within  the  Golgi.  If the  HA  were  present  in  the 
MansGlcNAc2 form, it should be sensitive to digestion by 
endo D, and we assessed this possibility. As a positive con- 
trol for the activity of endo D, the sensitivity of HA to endo 
D  in the CHO 15B cell line, which fails to add GlcNAc to 
glycoproteins in the medial Golgi, was measured. In CHO 
15B cells, all N-linked glycoproteins should retain sensitiv- 
ity to endo D  once in or past the cis-Golgi. CHO 15B and 
V.24.1  cells were incubated at high temperature as indicated 
in the legend to Fig. 2, infected with influenza virus, pulsed 
with Tran35S-label  for 5  min, and chased for 0.5  h.  Before 
the chase (Fig. 2, lanes 1 and 2), HA extracted from CHO 
15B cells was resistant to endo D, and was primarily in the 
Figure 2.  HA remains resistant  to digestion by endo D in V.24.1 
cells at the restrictive temperature.  Cells were incubated at 41~ 
for 2 h, placed at 39.5~  infected with influenza virus, pulsed for 
5 min with Tran35S-label at 4 h postinfection, and lysed after indi- 
cated chase times (A T). Cell lysates were treated with endo D as 
described in Materials and Methods. HA was immunoprecipitated, 
electrophoresed  in 7.5% SDS-polyacrylamide  gels,  and  radiola- 
beled proteins were detected by fluorography. HA synthesized in 
CHO 15B cells (lanes 1-4) served as a positive control for the activ- 
ity of endo D. The inferred mannose content of the HA species is 
listed on the left. 
Kao and Draper End4 Mutant of Chinese Hamster Ovary Cells  703 Figure 3. Folding of HA in V.24.1 cells assessed by sensitivity to trypsin. The folding of newly synthesized HA was determined by testing 
its sensitivity to trypsin. Trypsin cleaves the initial form of properly folded HA (HA0, Mr = 78000) into HA1 (Mr = 55,000) and HA2 
(Mr -" 27,000), whereas unfolded and misfolded HA is completely degraded. Cells were infected at the restrictive temperature with virus, 
radiolabeled, and lysed at the indicated times after radiolabeling as described in Materials and Methods. 75/zg of protein from each lysate 
was treated with TPCK-trypsin. Trypsin digestion was then stopped by the addition of soybean trypsin inhibitor. HA was immunoprecipi- 
tated with anti-HA antibodies, and electrophoresed in 12 % SDS-polyacrylamide  gels. Radiolabeled proteins were detected by fluorography. 
Man9  form.  After a  chase of 0.5  h,  HA appeared in  the 
Man, form (Fig. 2, lane 3) and was sensitive to endo D, as 
seen in lane 4 (Man0 is the endo D digestion produc0. This 
control experiment demonstrated that the endo D was active. 
With V.24.1  cells, all of the HA was completely resistant 
to endo D digestion, even at 4 h after radiolabeling (Fig. 2, 
lanes 5-12), indicating that the MansGlcNAc2  form was not 
accumulating.  Schwaninger et al.  (47)  recently presented 
evidence that the cis-Golgi compartment in CHO cells con- 
tained both N-acetylglucosamine transferase  I  and  a-l,2- 
mannosidase II in addition to c~-l,2-mannosidase I. The fail- 
ure of N-linked oligosaccharides to acquire  resistance to 
endo H  or to accumulate in the MansGlcNAc2  form sug- 
gests that glycoproteins are not reaching even the cis aspect 
of the Golgi complex in the mutant cells. 
Folding and Trimerization  of  HA Is Normal in V.24.1 
Cells at the Restrictive Temperature 
One explanation for the failure of glycoproteins to reach the 
Golgi in V.24.1 cells is that the lesion somehow impairs pro- 
tein folding or oligomerization within the ER.  It is well- 
documented that the transport of proteins out of the ER to 
the Golgi apparatus requires proper folding and oligomeriza- 
tion (10, 16, 37). To investigate the conformation of a secre- 
tory glycoprotein within the ER, we used established proce- 
dures (10, 16)to monitor the folding and trimerization of 
HA. Before folding, HA (referred to as HA0) is sensitive to 
digestion by trypsin but becomes resistant as it folds and 
trimerizes. Trypsinization of folded HA0 results in only two 
fragments, HA1 and HA2. To assess folding, mutant and pa- 
rental cells were infected with influenza virus at the restric- 
tive temperature and pulsed for 3  min with Tran35S-label. 
At times up to 15 min after the pulse, cells were lysed and 
extracts were incubated with trypsin. Trypsin inhibitor was 
added and immunoprecipitated HA was electrophoresed in 
SDS-polyacrylamide gels.  Samples  without trypsin treat- 
ment were included at times 0 and 15 min to assess the recov- 
ery of HA in the absence of trypsin (Fig. 3, lanes 1, 2 and 
& 9). In the presence of trypsin, the recovery of HA1 and 
HA2 was very low at time 0, indicating that HA had not yet 
folded and was digested by trypsin (Fig. 3, compare lane 1 
with 3 and lane 8 with 10). Maximum recovery of HA1 and 
HA2 was observed by 10 rain after the pulse, revealing the 
acquisition of trypsin resistance that accompanies folding. 
There was no apparent difference  between the mutant and pa- 
rental cells in the rate at which HA became trypsin resistant. 
HA trimerization in pulse-labeled cells was assessed by 
sedimenting cell lysates in sucrose gradients (9). As shown 
in Fig. 4, monomers of HA sedimented in fractions 6-8 of 
the gradients while trimers  (centered around  fraction  14) 
from the parental cells were observed within 5 rain of the 
chase and predominant by 10 rain of the chase period. There 
was no apparent difference in the rate of HA trimerization 
with the mutant cells (Fig. 4, right side). Altogether, the 
data in  Figs.  3  and 4  suggest that the secretory block in 
V.24.1 cells is not caused by a defect in the folding or oligo- 
merization of proteins in the ER. 
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Figure 4.  Rate of HA trimerization  in wild-type and mutant cells at the restrictive temperature.  Cells were incubated at the restrictive 
temperature,  infected with influenza virus and radiolabeled as described in Materials and Methods. The cells were lysed at different times 
after radiolabeling as indicated on the left side of the figure. The monomeric and trimeric forms of HA were separated in 5-25 % sucrose 
gradients. HA was then immunoprecipitated  from every other fraction collected from the gradients (fraction numbers are at the bottom 
of the figure), electrophoresed  in 7.5 % SDS-polyacrylamide gels, and proteins were detected by fluorography. 
HA Accumulates in a PostER Pre-Golgi Compartment 
Considering that HA does not appear to reach the Golgi, it 
should either be retained within the ER itself or be trans- 
ported as far as a compartment intermediate between the ER 
and the Golgi.  To investigate this,  we determined whether 
HA colocalized with a marker for the ER or with a marker 
for a post-ER compartment by immunofluorescence micros- 
copy. The ER was identified using antibodies to BiP, a solu- 
ble protein located primarily within the ER (37). The inter- 
mediate compartment was identified with antibody to p58, 
a 58-kD protein reported by Saraste and co-workers to reside 
in a reticular compartment intermediate between the ER and 
the cis-Golgi  and in the cis-Golgi  (44,  45). 
Wild-type and mutant cells were incubated at 41~  to initi- 
ate the lesion in the mutant cells and infected with influenza 
virus. The cells were then prepared for immunofluorescence 
microscopy to simultaneously visualize either HA and BiP 
(Fig.  5,  a-d),  or HA and p58 (Fig.  5,  e-h).  In wild-type 
cells, HA was predominantly in the Golgi and on the cell sur- 
face (Fig. 5, a  and e). In the mutant cells, HA appeared to 
be mainly in discrete vesicular structures concentrated in the 
nuclear area, but which were also present towards the cell 
periphery (Fig. 5, c and g). The nuclear envelope in the mu- 
tant cells appeared to contain HA and HA also was observed 
in the ER. The morphology of the ER, shown by the staining 
for BiP,  was similar in mutant and parental cells (Fig. 5,  b 
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BiP,  and  p58  in  mutant  and 
wild-type cells infected with vi- 
rus at the  restrictive  tempera- 
ture. Cells grown on glass cover- 
slips  were  incubated  at  41~ 
for 2  h  to elicit  the  tempera- 
ture sensitive lesion, shifted to 
39.5~  infected with virus, and 
fixed at4 h after infection. Cells 
were then  incubated with goat 
anti-HA (a, c, e, g), and either 
rabbit anti-BiP (b and d) or rab- 
bit anti-p58 (/and g) primary an- 
tibodies.  Secondary antibodies 
were Texas red-labeled mouse 
anti-goat IgG  and FITCqabeled 
mouse anti-rabbit IgG. 
and d), indicating that the ER was intact in V.24.1 cells (see 
also Fig. 7 d). In wild-type cells, most of the p58 appeared 
to be within small vesicles concentrated primarily around 
the nucleus (Fig.  5 f).  Most interesting,  however, was the 
colocalization of p58 and HA in vesicles of the mutant cells 
(Fig. 5, g and h). Considering that HA may not reach the cis- 
Golgi, and that anti-p58  could stain both the intermediate 
compartment and the cis-Golgi, vesicles containing both HA 
and p58 may be the intermediate compartment between the 
ER and the cis-Golgi. 
A Resident Golgi Protein Is Not Transported beyond 
the p58-containing  Compartment in V.24.1 Cells at 
the Restrictive Temperature 
To see whether the transport of an endogenous cell protein, 
in addition to a viral glycoprotein, was arrested at the com- 
partment defined by p58,  we treated mutant and parental 
cells with BFA for I h at 34~  to redistribute Golgi proteins 
to the ER. The cells were then incubated for 2 h at 41~  to 
induce the lesion in the mutant cells and a  control sample 
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duced to enter the ER by BFA 
accumulates in the intermedi- 
ate  compartment  in  V.24.1 
cells upon removal of BFA at 
41~  Cells grown on cover- 
slips were treated with 5 t~g/ 
ml BFA at the permissive tem- 
perature for 1 h and then in- 
cubated for 2 h in the presence 
of  the  drug  at  41~  BFA 
was then removed by extensive 
washing and the cells were ei- 
ther fixed immediately (a-d) 
or incubated for an additional 
0.5 h at 41~  in the presence 
of cycloheximide before fixa- 
tion  (e-h).  The  cells  were 
stained for  double immunoflu- 
orescence using rat anti-gp125 
and rabbit anti-p58 followed  by 
FI-TC-conjugated  donkey anti- 
rat IgG  and  Texas red-con- 
jugated mouse anti-rabbit IgG. 
of each cell type was fixed at this time. The remaining cells 
were washed to remove BFA and incubation at 41~  was con- 
tinued for 0.5 h to allow transport of Golgi proteins in the 
ER back to the Golgi. Cells were then prepared for double 
immunofluorescence staining to simultaneously detect p58 
and gp125, an integral membrane protein associated with the 
cis/medial-Golgi (Fig. 6). In the presence of  BFA, a coherent 
perinuclear Golgi complex was not evident in either wild- 
type (Fig. 6 a) or mutant cells (Fig. 6 c) as expected. The 
intermediate compartment defined by p58  was  present in 
both cell types in the presence of the drug (Fig. 6, b and d), 
consistent with observations by Lippincott-Schwartz et al. 
(25) that the intermediate compartment persists in the pres- 
ence of BFA. When BFA was removed and the cells were in- 
cubated at the restrictive temperature for an additional half 
hour, the Golgi complex reassembled in the wild-type cells 
(Fig. 6 e) but not in the V.24.1 cells (Fig. 6 g). In the mutant 
cells, gp125 colocalized with p58 in discrete vesicular struc- 
tures (compare Fig. 6, g and h), similar to the colocalization 
of HA with p58 in Fig. 5. This indicates that the failure to 
be transported beyond the p58-containing compartment is 
not specific to a viral glycoprotein, but also occurs with an 
endogenous Golgi protein, gp125. 
Disappearance of the Golgi Complex in V.24.I Cells 
at the Restrictive Temperature 
To see what effect the lesion in the mutant cells had on the 
morphology of the Golgi complex, mutant and  wild-type 
cells were incubated at 41~  for 2 h and were prepared for 
immunofluorescence microscopy to simultaneously observe 
gp125  and either ribophorin II (an ER resident protein) or 
p58. The morphology of the ER (compare Fig. 7, b and d) 
was  similar  in the mutant and wild-type cells,  as was the 
morphology of the intermediate compartment (compare Fig. 
7, f  and h), suggesting that the structure of these two com- 
partments was not severely affected by the lesion in the mu- 
tant cells. However, the Golgi complex, readily identified by 
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ribophorin II, and p58 in mu- 
tant and wild-type cells at the 
restrictive  temperature.  Cells 
grown on glass coverslips were 
incubated at 41~  for 2 h, fixed, 
permeabilized, and then stained 
for double immunottuorescence 
using  antibodies as  indicated. 
(a-d) Cells incubated with rat 
anti-gp125 and mouse antiribo- 
phorin  II  primary  antibodies 
followed by FITC-labeled don- 
key anti-rat IgG and Texas red- 
labeled  goat  anti-mouse  IgG 
as secondary antibodies. (e-h) 
Cells  incubated with  rat  anti- 
gpl25  and rabbit anti-p58 pri- 
mary  antibodies  followed by 
FITC-labeled  donkey  anti-rat 
IgG and Texas  red-labeled  mouse 
anti-rabbit  IgG  as  secondary 
antibodies. 
staining for gp125 in the wild-type cells (Fig. 7, a and e), was 
hardly visible above the background in V.24.1  cells (Fig. 7, 
c and g). Within the resolution of fluorescence microscopy, 
it did not appear as ifgp125 had left the Golgi and distributed 
to either the ER or the p58-containing compartment in the 
mutant cells. 
To verify the apparent absence of the Golgi complex in 
V.24.1 cells, we used a different marker, mannosidase II (an- 
other Golgi-associated integral membrane protein) (25), and 
monitored the rate of the Golgi disappearance upon shifting 
cells to the restrictive temperature. As seen in Fig. 8 (a and 
b), the morphology of the wild-type Golgi complex stained 
for mannosidase  II  was  similar  to  that  when  stained  for 
gp125 in Fig. 7 (a and e). In addition, the Golgi in the wild- 
type cells looked similar at 34 and 41~  There was also little 
difference between the Golgi in V.24.1  cells and wild-type 
cells at 34~  (Fig. 8, a and c). However, after 15 min at the 
restrictive temperature the Golgi complex in V.24.1 cells ap- 
peared  to  fragment  into  vesicles  that  with  time  became 
smaller and more dispersed throughout the cytoplasm until 
by  120  min there was  little visible evidence of the Golgi 
(Fig. 8, d-h).  The 58-kD protein did not colocalize in vesi- 
The Journal of Cell Biology, Volume 117,  1992  708 Figure 8. The rate of Golgi complex disappearance in V.24.1 cells at the restrictive temperature. Cells grown on glass coverslips were 
incubated at 41~  for the times indicated. The cells were then fixed, permeabilized, and stained for immunofluorescence  using rabbit anti- 
mannosidase II followed by rhodamine-labeled goat anti-rabbit IgG. 
cles with gp125 during the fragmentation process (data not 
shown), evidence that Golgi proteins did not accumulate in 
an intermediate compartment occupied by p58 as the frag- 
mentation process progressed. The Golgi complex was also 
not visible by 2 h at 41~  when stained with the fluorescent 
sphingolipid C6-NBD-ceramide (34),  suggesting that both 
Golgi proteins and Golgi lipids dispersed in the mutant cells 
(data not shown). 
Kao and Draper End4 Mutant of Chinese Hamster Ovary Cells  709 Figure  9. Golgi carbohydrate processing enzymes do not appear to return to the ER in V.24.1 cells at the restrictive temperature. Wild-type 
and mutant cells were infected with influenza virus at 34~  and incubated at 34~  for an additional 6 h to express HA before temperature 
shift (a, c, d) or the addition ofBFA (b). BFA (final concentration 5/~g/ml) was added either at 41~  (a and d), or at 34~  before the 
shift to 41~  (b), or not at all (c). Cells were pulsed with Tran35S-label  for 5 min and chased for the times indicated. For b, 100 #tM 
of cycloheximide was added with BFA and was kept in the medium throughout the experiment to stop new protein synthesis except during 
pulse labeling. HA was immunoprecipitated, digested with endo H, electrophoresed and detected as described in Materials and Methods. 
Golgi Carbohydrate-processing Enzymes Fail 
to Process N-linked Oligosaccharide Chains of  HA 
in the ER of V.24.1 Cells at High Temperature 
The disappearance of the Golgi complex in the mutant cells 
is reminiscent of  the loss of  the Golgi in cells caused by BFA 
(12-14, 24, 25, 33). However, it did not appear that gp125 
or mannosidase II were redistributing to the ER by immuno- 
fluorescence microscopy. Nevertheless, the two Golgi pro- 
teins may have been too dilute in the ER to detect. Therefore, 
we checked the return of Golgi carbohydrate processing en- 
zymes to the ER by their ability to modify the N-finked 
oligosaccharides of HA within the ER. AS one control, we 
measured the capacity of BFA to  induce Golgi carbohy- 
drate-processing enzymes to return to the ER at high tem- 
perature in wild-type cells. The procedure is summarized at 
the left of Fig. 9 a. Cells were infected with influenza virus 
at 34~  and incubated for an additional 6 h to express HA, 
placed at 41~  treated with BFA, pulsed for 5  rain with 
Tran35S-label,  and chased for different times. HA was im- 
munoprecipitated and treated with endo H to see if  carbohy- 
drate processing of HA had occurred in the ER. As seen in 
the fight portion of Fig. 9 a, by 4 h of the chase, almost all 
of the HA had been processed to the endo H-resistant form, 
demonstrating the validity of the assay. As a second control, 
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the disappearance  of  the Golgi 
complex in V.24.1 cells. Cells 
were incubated 2 h at 41"C in 
the absence (a and b) or the 
presence (c and d) of monen- 
sin (10 #M), fixed, permeabi- 
lized, and stained for gp125 
as in Figs. 6 and 7. Cyclohex- 
imide was present in all me- 
dia during 41"C incubation to 
block  the  synthesis of new 
gp125. 
we added BFA to induce Golgi enzymes to return to the ER 
in V.24.1 cells at 34~  and then raised the temperature and 
assessed the effects on the endo H sensitivity of HA (Fig. 9 
b).  Cycloheximide was added together with BFA and was 
present throughout the experiment except during pulse label- 
ing to eliminate the possibility of HA being processed by 
newly synthesized Golgi carbohydrate processing enzymes 
retained in the ER by BFA treatment. HA became resistant 
to endo H by 4 h of  chase, demonstrating that Golgi carbohy- 
drate processing enzymes were not inactivated in the mutant 
cells simply by raising the temperature to 41~  Next, we de- 
termined whether incubating V.24.1 cells at 41~  in the ab- 
sence of BFA resulted in processing of HA to endo H resis- 
tance. As shown in Fig. 9 c, HA remained sensitive to endo 
H, even after 6 h at 41~  strongly suggesting that the lesion 
in V.24.1 cells was not causing Golgi enzymes to enter the 
ER. Furthermore, there was no processing of HA oligosac- 
charides even when BFA was added to V.24.1 cells after they 
had  been  incubated at  high temperature  (Fig.  9  d).  Al- 
together, this data indicates that the effects of the lesion on 
the Golgi complex in the mutant cells is not identical to the 
effects of BFA on the Golgi. 
Monensin Retards the Disappearance 
of the Golgi Complex 
Two different kinds of mechanism could underlie the appar- 
ent disappearance of the Golgi complex in the mutant cells. 
One possibility is that some aspect of membrane transport 
between Golgi cisternae  participates  in  dissipating Golgi 
membrane.  Alternatively, the Golgi might somehow dissi- 
pate without need for any specific membrane transport pro- 
cess. If transport between Golgi cisternae is necessary for 
the Golgi to disappear, then inhibiting transport should re- 
sult in the persistence of the Golgi at the restrictive tempera- 
ture.  The  proton  ionophore  monensin,  which  exchanges 
protons  for  sodium across  membranes,  inhibits transport 
between cisternae  of the Golgi  (18, 53).  To  see whether 
monensin had an effect on the disappearance of the Golgi 
complex, wild-type and V.24.1 cells were incubated at 41~ 
for 2 h without (Fig. 10, a and b) or with (Fig. 10, c and d) 
monensin and stained with antibody to gp125. The Golgi 
complex was still visible in mutant cells treated with monen- 
sin, but not in the control cells in the absence of the drug. 
This result suggests that whatever process underlies the dis- 
appearance of the Golgi complex, membrane transport be- 
tween Golgi cisternae is involved. In further experiments we 
extended the incubation at 41~  in the presence of monensin 
up to 4 h and observed that, given the additional time, the 
Golgi complex did eventually disappear (data not shown). 
Thus, monensin delays, but does not completely stop, the 
disappearance of the Golgi complex in V.24.1  cells. 
Another activity of monensin is to raise lysosomal pH, 
which blocks degradation of material within lysosomes (28). 
If Golgi membrane were aberrantly entering lysosomes in 
the mutant cells, then undegraded Golgi proteins might ac- 
cumulate in lysosomes in the presence of monensin. How- 
ever,  we observed no accumulation of gp125  within lyso- 
somes during prolonged treatment with the drug (data not 
shown). Treating cells with the lysosomotropic drug chloro- 
quine, which also inhibits digestion in lysosomes (I1), also 
did not result in visible accumulation of gp125 in lysosomes 
(data not shown). 
The Disappearance of the Golgi Complex 
in V.24.I Cells Is Not a Consequence of 
Micratubule Depolymerization 
The depolymerization of rnicrotubules in intact cells causes 
the Golgi complex to fragment and then disperse throughout 
the cytoplasm (35, 40, 41, 55). It was possible, therefore, that 
the fragmentation of the Golgi in the mutant cells could be 
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the disappearance of the Golgi complex 
in V.24.1 cells. In a and b, cells were 
incubated at 41~  for 2 h, fixed, and 
incubated with  mouse  antityrosinated 
tubulin  followed  by a secondary  antibody 
of RITC-conjugated  goat antimouse. In 
c and d, cells were incubated at 34~ 
with nocodazole (20/~g/ml) for 2 h and 
shifted to 41"C for an additional 2 h in 
the presence of nocodazole. The cells 
were stained to detect Golgi mannosi- 
dase It as in Fig. 8. 
caused by a loss in the integrity of microtubules. To inves- 
tigate the possibility that microtubules were depolymerized 
in V.24,1 cells at the nonpermissive temperature, mutant and 
wild-type ceils were incubated at 41~  and stained for tubu- 
lin. The microtubular network looked the same in both cells 
(Fig. 11, a and b), evidence that the lesion in V.24.1 cells was 
not correlated with any gross depolymerization of microtu- 
butes. In addition, we compared the morphology of  the Golgi 
complex in mutant and wild-type cells that were pretreated 
at 34~  with nocodazole to depolymerize microtubules, in- 
cubated at high temperature for 2  h  with nocodazole, and 
then stained for mannosidase II (Fig. 11, c and d). In wild- 
type cells, the Golgi complex fragmented  when microtubules 
wore depolymerized, but the fragments were large and visi- 
ble at all times. Interestingly, when microtubules were de- 
polymerized in V.24.1 ceils before incubation at the restric- 
tive temperature for 2 h, the Golgi complex fragmented to 
the extent seen in wild-type cells with nocodazole, but did 
not disappear as when nocodazole was absent (compare Fig. 
11, d and 8 h). Upon longer incubation at the restrictive tem- 
perature, the Golgi complex did eventually disappear (data 
not shown), analogous to results with monensin, indicating 
that nocodazole retarded, but did not completely inhibit, the 
loss of the GolgL The disappearance of the Golgi complex 
in V.24.1 cells at high temperature appears to be fundamen- 
tally different than the fragmentation of the Golgi complex 
in cells that have depolymerized microtubules. 
Discussion 
V.24.1 cells define the End4 complementation group of tem- 
perature-sensitive CHO cell mutants selected for resistance 
to protein toxins (7).  Previous studies indicated that the 
properties of mutant V.24.1 are consistent with the presence 
of a single and revertible genetic lesion that creates a tem- 
perature-sensitive protein (8). We recently reported that se- 
cretion in V.24.1 cells was blocked at a step before the medial 
Golgi (39, 56).  In 1985, Nakano et al. (31) described a tem- 
perature-sensitive mutant of  CHO cells, termed DS28-6,  that 
had a similar secretion-defective  phenotype. We have recently 
analyzed somatic cell hybrids made by fusing V.24.1  and 
DS28-6 cells and found  that the hybrids have the mutant phe- 
notype, indicating that the two mutants are in the same com- 
plementation group  (Wang,  R.-H.,  E  A.  Colbaugh,  and 
R. K. Draper, unpublished work). Another mutant, termed 
HRP-1, independently isolated in this tab using a new selec- 
tion scheme, also failed to complement the lesion in V.24.1 
and DS28-6 cells (Wang, R.-H., E  A. Colbaugh, and R. K. 
Draper,  unpublished work).  Thus,  there are now at least 
three independently isolated members of the End4 comple- 
mentation group. 
A failure to secrete glycoproteins could be a consequence 
of aberrant folding or otigomerization in the ER, leading to 
retention of misfolded proteins. However, this does not ex- 
plain the defect in End4 mutants, because HA folded and 
trimerized at the same rate in V.24.1  and wild-type cells at 
the restrictive temperature. The failure to secrete could also 
be related to unusual protein glycosylation, since Hearing et 
al.  (19, 20)  reported that addition of truncated  N-linked 
oligosaccharides to HA impaired secretion in a temperature- 
sensitive mutant of CHO cells.  However,  in  the  present 
work, and in previous studies (39, 56), we have not observed 
any unusual electrophoretic migration of newly synthesized 
glycoproteins in SDS-polyacrylamide gels that would sug- 
gest aberrant or heterogeneous oligosaccharides were pres- 
ent on glycoproteins. There is no evidence that the failure of 
End4 mutants to secrete is related to structural or conforma- 
tional abnormalities of secretory proteins. 
Journal of Cell Biology, Volume I17, 1992  712 The Intermediate Compartment 
Morphological (43, 44, 49) and biochemical (3, 50, 54) evi- 
dence in recent years has supported the presence of a com- 
partment intermediate between the ER and the cis-Golgi in 
mammalian  cells.  The  intermediate  compartment  is pro- 
posed  to function  in the retrieval of resident ER proteins 
back to the ER (36, 37, 57), in O-glycosylation (54) and in 
phosphorylation  of lysosomal  enzymes (36, 37). Several 
lines of evidence support  the idea that secretory material 
enters a compartment intermediate between the ER and the 
Golgi in V.24.1 cells at the restrictive temperature, but is not 
transported on to the Golgi apparatus. HA from mutant cells 
infected with influenza virus at the restrictive temperature 
did not become resistant to digestion by endo H or sensitive 
to digestion by endo D. Since all of the enzymes needed to 
convert N-linked oligosaccharides  to either endo H resis- 
tance or endo D sensitivity are probably present to some ex- 
tent in the cis-Golgi of CHO cells (47), this implies that the 
block in secretion is before the cis-Golgi, either in the ER 
or in a compartment intermediate between the cis-Golgi and 
the ER. Observation by immunofluorescence microscopy of 
HA in mutant cells showed that most of the HA was within 
vesicles that did not resemble the ER (or the Golgi), but were 
similar to the intermediate  compartment  others  have ob- 
served  by immunofluorescence microscopy  (44,  48).  The 
HA-containing vesicles also contained p58, a protein reported 
to reside in the intermediate compartment and the cis-Golgi 
(44, 45), consistent with the possibility that HA was in the 
intermediate compartment since it is unlikely that HA reached 
the cis-Golgi. Vesicles containing HA and p58 were not a 
collapsed form of the ER caused by the mutation in V.24.1 
cells because the morphology of the ER was normal as as- 
sessed by staining for the ER proteins BiP and ribophorin II. 
A Golgi protein, gp125, that had been induced to return to 
the ER by addition of BFA at the permissive temperature, 
also accumulated in the p58-containing vesicles when BFA 
was removed at the restrictive temperature. This demonstrated 
that viral infection is not a factor in the accumulation of pro- 
teins between the ER and the Golgi. 
The simplest  interpretation  of our observations  is  that 
secretion is blocked in V.24.1 cells at the level of  export from 
the intermediate compartment  defined by others.  However, 
there are alternative possibilities. The compartment in which 
HA accumulates  could represent  a collection of transport 
vesicles en route from the ER to the intermediate compart- 
ment, or en route from the intermediate compartment to the 
Golgi. It is also possible that HA accumulates in a special 
subdomain of  the ER, such as the transitional ER, especially 
if p58 were to collect in this subdomain in the mutant cells 
but not parental  cells. 
The intermediate  compartment consists  of vesicles and 
tubules that are frequently, although not always, very close 
to the cis-Golgi (43-45, 49). As a result, the relationship be- 
tween the cis-Golgi and the intermediate compartment has 
been difficult to define. When cells are treated with nocoda- 
zole to depolymerize microtubules and disperse the Golgi, 
the intermediate compartment appears to go with the Golgi 
as if they were one organelle (5, 25, 44). However, in BFA- 
treated cells, the Golgi merges with the ER, but the inter- 
mediate compartment retains at least some structural iden- 
tity (25, 44), suggesting the two compartments are different. 
To the extent that p58 marks the intermediate compartment 
in the mutant cells, the lesion in End4 mutants distinguishes 
between the Golgi and the intermediate compartment since 
the Golgi complex vanishes at the restrictive  temperature 
while the p58-containing compartment persists. 
Disappearance of the Golgi Complex 
The Golgi complex could not be detected by immunofluores- 
cence microscopy  in V.24.1 cells after 2 h at 41~  when 
stained  with anti-gp125, antimannosidase  II, or Ct-NBD- 
ceramide.  It should be emphasized that the Golgi complex 
disappears at the resolution of fluorescence microscopy: ul- 
trastructural  studies are in progress and it is possible that 
Golgi remnants may be identified at high resolution. The ab- 
sence of the Golgi agrees with the recent report of Zuber et 
al. (59) that the Golgi complex disappeared at high tempera- 
ture in mutant DS28-6, which is in the same complementa- 
tion group as mutant V.24.1. Zuber et al.  (59) further re- 
ported several aspects of the disappearing Golgi in DS28-6 
cells that were similar to the effects of BFA on the Golgi. (a) 
The redistribution of the Golgi enzymes mannosidase II and 
galactosyl transferase to the ER by immunofluorescence mi- 
croscopy. (b) The redistribution of a Golgi lipid marker to 
the ER by immunofluorescence microscopy. (c) The pres- 
ence  of complex  carbohydrates  in  the ER  detected  with 
lectin-gold labeling, consistent with the possibility of  Golgi- 
associated carbohydrate-processing enzymes being returned 
to the ER. Our data differ regarding the analogy between 
BFA and the lesion in End4 mutants. While we have no ultra- 
structural data to indicate where the Golgi is going, we did 
not observe a clear accumulation of  Golgi protein or lipid in 
the ER by immunofluorescence. This could be explained if 
our experiments were not sensitive enough to detect Golgi 
markers diluted into the ER. However, we also did not bio- 
chemically detect processing of  N-linked oligosaccharides of 
HA in the ER by Golgi enzymes. 
One explanation to account for the disappearance of the 
Golgi is that Golgi components might be returning to the ER 
as in BFA-treated cells, but in a fashion that somehow does 
not result in the processing of N-linked oligosaccharides by 
Golgi enzymes in the ER. The complex carbohydrate within 
the  ER  observed  by  Zuber et  al.  (59) using  lectin-gold 
cytochemistry could have come from preexisting glycopro- 
teins transported from the Golgi to the ER rather than by pro- 
cessing of oligosaccharide  chains in the ER.  However, the 
possibility that Golgi components are not returning to the ER 
cannot be dismissed and we can think of three explanations 
that might account  for this~ First,  Gotgi membrane  might 
fragment  into vesicles  too  small  to  be  detected  by  im- 
munofluorescence microscopy if vesicles involved in trans- 
port between Golgi cisternae formed but did not bind to or 
fuse with their target membranes. Conceivably, the vesicles 
might require microtubules to disperse throughout the cyto- 
plasm. This mechanism is similar to that proposed to explain 
the fragmentation  of the Golgi during mitosis  (15, 26, 27) 
and it is possible that the Golgi undergoes premature mitotic 
breakdown in the mutant cells. Second, the Golgi might dis- 
appear if secretory transport out of the Golgi were to con- 
tinue  while  compensatory  replacement  of secreted  mem- 
brane  was blocked due to the lesion.  Secretion would be 
delayed by monensin  and nocodazole,  accounting  for the 
persistence of the Golgi in the presence of the drugs. If the 
secretion model were correct, we might have expected in our 
Kao and Draper End4 Mutant of Chinese Hamster Ovary Cells  713 immunofluorescence studies to have  seen gp125  and man- 
nosidase II in the plasma membrane, or possibly in vesicles 
of the endocytic  apparatus,  but we did not.  However,  the 
Golgi proteins might not have  been detected if they  were 
highly  diluted  in  cell  surface  and  endocytic  membranes. 
Third, Golgi membrane might be degraded by a process that 
requires  membrane transport  and microtubules.  Although 
we did not observe any accumulation of gp125  in lysosomes 
in the presence of monensin or chloroquine to inhibit lysoso- 
mal degradation,  there may not have been enough gp125  in 
lysosomes to detect.  Moreover,  it is possible that degrada- 
tion is by a nonlysosomal process. Further work is necessary 
to understand  what happens to the Golgi in V.24.1  cells. 
The Primary Lesion 
Considering  that high temperature  causes both  the disap- 
pearance of the Golgi complex and blocks transport  to the 
Golgi, what is the primary  lesion in the mutant cells? Does 
the Golgi disappear because transport is blocked, or does the 
Golgi complex first disappear,  which somehow blocks secre- 
tory transport  because there is no recipient Golgi?  When 
cells were treated with BFA at 34~  to insure retraction  of 
Golgi components into the ER, and then incubated  at the re- 
strictive temperature  in the absence of BFA, the Golgi did 
not reform; instead, gp125  accumulated in the p58-contain- 
ing compartment. This argues that the primary  lesion has a 
direct effect on the export of secretory material from the p58- 
containing compartment. This does not exclude the possibil- 
ity that a single lesion might block secretory transport at two 
steps, from the ER to the Golgi as well as transport between 
Golgi cisternae,  and that  Golgi  membrane  somehow dis- 
perses as a consequence.  However, this idea is difficult to 
reconcile with the observation that monensin retarded disap- 
pearance  of the  Golgi,  suggesting  that  transport  between 
Golgi cisternae might be necessary for Golgi disappearance. 
A primary effect of the lesion on transport to the Golgi is also 
consistent with the observation that the block in ER to Golgi 
transport  was complete within 60-90  rain of elevating  the 
temperature,  a time at which the Golgi was still morpho- 
logically visible. 
In summary,  our current model is that End4 mutants con- 
tain  a  temperature-sensitive  mutation  affecting  a  protein 
necessary for transport of material between the ER and the 
Golgi, probably at the level of export from a compartment 
intermediate between the ER and the Golgi. The Golgi com- 
plex apparently disappears  as a result of this block, but what 
happens to the Golgi is not yet clear. We are presently inves- 
tigating  the defect in End4 mutants  using in vitro assays  of 
membrane transport  and morphological approaches. 
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